Drupal.behaviors.print = function(context) {window.print();window.close();}>
Exact Sciences Posts Flat Q1 Revenues; Loss More than Doubles as Clinical Trial Costs Spike
May 01, 2012
Exact Sciences Posts Flat Q1 Revenues; Loss More than Doubles as Clinical Trial Costs Spike
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Exact Sciences Cuts Loss in Q3
November 3, 2009 / GenomeWeb Daily News
Exact Sciences Completes PMA Submission to FDA for Cologuard
June 10, 2013 / GenomeWeb Daily News
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
Nanosphere Q1 Revenues Rise 85 Percent; Secures $27M in Financing
May 8, 2013 / GenomeWeb Daily News
UPDATE: Exact Sciences Reports Flat Q1 Revenues
May 1, 2013 / GenomeWeb Daily News